Companies similar to MONOPAR THERAPEUTICS INC (MNPR)
Health Care · NASDAQ
MONOPAR THERAPEUTICS INC (MNPR)'s closest peers include ASTRAZENECA PLC (AZN), NOVARTIS AG (NVS) and PERSPECTIVE THERAPEUTICS INC (CATX). This peer set is drawn from MNPR's enriched company profile and is informational only — not financial advice.
Similar companies
-
ASTRAZENECA PLCAZN
Leading global biopharmaceutical company developing targeted oncology, cardiovascular, and rare disease treatments backed by a strong R&D pipeline.
$169.34 (as of 2026-07-21) · market cap $195.3B
-
NOVARTIS AGNVS
Global pharmaceutical and biotechnology company pioneering disease-modifying treatments across oncology, immunology, neuroscience, and rare genetic diseases.
$153.87 (as of 2026-07-21) · market cap $228.2B
-
PERSPECTIVE THERAPEUTICS INCCATXHealth Care
Perspective Therapeutics is a clinical-stage oncology company pioneering targeted alpha therapy (TAT) to treat cancer through a proprietary radiopharmaceutical…
$2.98 (as of 2026-07-21) · market cap $333M
Not quite? Describe exactly what you want →
Peers are drawn from MNPR's enriched profile (the same similarity signal the chat uses for "companies like MNPR"). See the full profile: MONOPAR THERAPEUTICS INC (MNPR).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.